GCH1 and endothelial dysfunction: Therefore, they also represent pharmacological targets for the correction of endothelial dysfunction and the prevention of the progression of cardiovascular disease [63,64], as also demonstrated by the prevention of vascular complications in diabetic or hypertensive animals by endothelium-specific overexpression of GTPCH-I [11,65].